abatacept vs tapentadol
Side-by-side comparison of abatacept and tapentadol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Orencia
Nucynta
Orencia is a medicine that helps to reduce inflammation. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis.
Nucynta is a strong pain medicine. It is used to treat severe acute pain when other pain medicines are not strong enough.
Orencia treats rheumatoid arthritis in adults. It also treats polyarticular juvenile idiopathic arthritis in patients 2 years and older. Orencia can also treat active psoriatic arthritis in patients 2 years and older. Finally, it can prevent acute graft versus host disease after a stem cell transplant.
Nucynta is used to manage acute pain in adults and children (6 years and older weighing at least 88 pounds). This medicine is for severe pain that requires an opioid pain reliever. It is used when other pain treatments are not adequate.
Orencia works by blocking the activity of certain immune cells called T cells. These T cells can cause inflammation and damage to your joints and other tissues. By blocking T cell activity, Orencia can help reduce inflammation and relieve your symptoms.
Nucynta works in two ways to relieve pain. It acts on opioid receptors in the brain to reduce pain signals. It also prevents the reuptake of norepinephrine, which can also help reduce pain.
- • Headache
- • Upper respiratory tract infection (like a cold)
- • Runny nose
- • Nausea
- • Feeling sick to your stomach (nausea)
- • Feeling dizzy
- • Throwing up (vomiting)
- • Feeling sleepy
- The medicine is not working 38,612
- Rheumatoid arthritis 23,596
- Pain 21,295
- Joint pain 20,151
- Swollen joint 19,709
- Death 11,543
- Harm from drugs or chemicals 9,292
- Took too much medicine 5,817
- Misusing medicine 1,414
- Need for the drug 977
Using Orencia with a TNF antagonist or other biologic medicines can raise your risk of serious infections. Tell your doctor if you have any signs of infection, such as fever, cough, or sore throat. Orencia can also cause allergic reactions, including anaphylaxis. Get medical help right away if you have trouble breathing, swelling, or hives.
Nucynta can cause addiction, abuse, and misuse, which can lead to overdose and death. Your doctor will check your risk before prescribing and regularly during treatment. This medicine can also cause life-threatening breathing problems, especially when you start taking it or after a dose increase. Taking Nucynta with benzodiazepines (like Xanax or Valium), alcohol, or other CNS depressants can cause sleepiness, slowed breathing, coma, and death. Accidental ingestion, especially by children, can cause a fatal overdose. If you are pregnant and use Nucynta for a long time, your baby could have withdrawal symptoms after birth.
There is not enough information about Orencia use in pregnant women to know if it is safe. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Using Nucynta for a long time during pregnancy can cause withdrawal symptoms in the newborn. Talk to your doctor about the risks if you are pregnant or plan to become pregnant. If you are breastfeeding, monitor your baby closely for any signs of drowsiness or breathing problems.
How to Read This abatacept vs tapentadol Comparison
abatacept is classified in the T-Cell Co-Stimulation Modulator drug class, while tapentadol sits within the Opioid / Norepinephrine Reuptake Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abatacept has 123,363 submissions while tapentadol has 29,043. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abatacept and tapentadol — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.